Literature DB >> 3365966

Allergy to non-toxoid constituents of vaccines and implications for patch testing.

N H Cox1, C Moss, A Forsyth.   

Abstract

We report 3 patients with persistent symptoms at vaccination sites. All were allergic to aluminium and one to thiomersal and neomycin too. Aluminium allergy causes false positive patch test reactions and we propose methods of patch testing patients with symptoms at vaccination sites in order to avoid this problem. The practical relevance of allergy to non-toxoid constituents of vaccines is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3365966     DOI: 10.1111/j.1600-0536.1988.tb04500.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  7 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

2.  Nineteen cases of persistent pruritic nodules and contact allergy to aluminium after injection of commonly used aluminium-adsorbed vaccines.

Authors:  Elisabet Bergfors; Cecilia Björkelund; Birger Trollfors
Journal:  Eur J Pediatr       Date:  2005-07-26       Impact factor: 3.183

3.  Pulmonary and cutaneous vasculitis following hepatitis B vaccination.

Authors:  M B Allen; P Cockwell; R L Page
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

Review 4.  Vaccines without thiomersal: why so necessary, why so long coming?

Authors:  A J van't Veen
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Aluminium and injection site reactions.

Authors:  G A Culora; A D Ramsay; J M Theaker
Journal:  J Clin Pathol       Date:  1996-10       Impact factor: 3.411

Review 6.  Vaccine allergies.

Authors:  Eun Hee Chung
Journal:  Clin Exp Vaccine Res       Date:  2013-12-18

7.  Harnessing co-operative immune augmentation by contact allergens to enhance the efficacy of viral vaccines.

Authors:  Louise S Cunningham; John P McFadden; David A Basketter; Felicity J Ferguson; Ian R White; Ian Kimber
Journal:  Contact Dermatitis       Date:  2020-09-04       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.